17.50
4.98%
0.83
Vorhandelsmarkt:
17.25
-0.25
-1.43%
Schlusskurs vom Vortag:
$16.67
Offen:
$17.2
24-Stunden-Volumen:
1.79M
Relative Volume:
1.95
Marktkapitalisierung:
$1.33B
Einnahmen:
$492.05M
Nettoeinkommen (Verlust:
$197.92M
KGV:
7.6087
EPS:
2.3
Netto-Cashflow:
$176.12M
1W Leistung:
+1.63%
1M Leistung:
+2.88%
6M Leistung:
+1.98%
1J Leistung:
-27.08%
Inmode Ltd Stock (INMD) Company Profile
Vergleichen Sie INMD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
17.50 | 1.33B | 492.05M | 197.92M | 176.12M | 2.30 |
ABT
Abbott Laboratories
|
129.10 | 223.92B | 41.95B | 13.40B | 6.49B | 7.65 |
BSX
Boston Scientific Corp
|
103.54 | 152.60B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
392.39 | 149.59B | 22.60B | 2.99B | 3.49B | 7.76 |
MDT
Medtronic Plc
|
90.97 | 116.65B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
71.33 | 42.07B | 6.60B | 4.16B | 490.10M | 6.93 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-17 | Eingeleitet | BTIG Research | Buy |
2024-07-23 | Herabstufung | Jefferies | Buy → Hold |
2023-11-03 | Herabstufung | UBS | Buy → Neutral |
2023-10-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
2023-03-29 | Eingeleitet | UBS | Buy |
2023-02-17 | Herabstufung | Needham | Buy → Hold |
2022-12-21 | Eingeleitet | Barclays | Overweight |
2022-10-12 | Eingeleitet | Jefferies | Buy |
2021-05-25 | Eingeleitet | Barclays | Overweight |
2021-05-18 | Eingeleitet | Needham | Buy |
2019-09-03 | Eingeleitet | Barclays | Overweight |
2019-09-03 | Eingeleitet | Canaccord Genuity | Buy |
2019-09-03 | Eingeleitet | Robert W. Baird | Outperform |
2019-09-03 | Eingeleitet | UBS | Buy |
Alle ansehen
Inmode Ltd Aktie (INMD) Neueste Nachrichten
InMode Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
InMode Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
InMode: Q4 Earnings Snapshot - The Washington Post
InMode Reports Fourth Quarter and Full Year 2024 Financial Resul - GuruFocus.com
InMode earnings missed by $0.17, revenue fell short of estimates - Investing.com India
Inmode Reports Q4 And FY 2024 Results; Board Approves New Share Repurchase Program - Marketscreener.com
InMode Reports Decrease in 2024 Revenues, Announces New Share Repurchase Program - TipRanks
Earnings Flash (INMD) INMODE LTD. Posts Q4 Adjusted EPS $0.42, vs. FactSet Est of $0.53 - Marketscreener.com
InMode: Q4 Earnings Snapshot -February 04, 2025 at 07:17 am EST - Marketscreener.com
InMode reports revenue dip, plans share repurchase - Investing.com
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program - PR Newswire
InMode (INMD) to Release Quarterly Earnings on Tuesday - MarketBeat
InMode Ltd. (NASDAQ:INMD) Shares Sold by Boston Trust Walden Corp - MarketBeat
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference - StreetInsider.com
InMode Ltd. (NASDAQ:INMD) Stake Cut by SG Americas Securities LLC - MarketBeat
[Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
InMode Ltd. (NASDAQ:INMD) Receives $22.40 Consensus Target Price from Brokerages - MarketBeat
Do Options Traders Know Something About InMode (INMD) Stock We Don't? - Yahoo Finance
InMode: A Clear Bargain With Unique Risks (NASDAQ:INMD) - Seeking Alpha
Inmode Ltd to Host Earnings Call - ACCESS Newswire
Objective long/short (INMD) Report - Stock Traders Daily
InMode (NASDAQ:INMD) earnings and shareholder returns have been trending downwards for the last three years, but the stock rallies 5.1% this past week - Yahoo Finance
INMDInMode Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced - Nasdaq
DOMA Perpetual urges InMode for immediate tender offer By Investing.com - Investing.com Australia
DOMA Perpetual urges InMode for immediate tender offer - Investing.com
InMode Shareholder Demands 30% Tender Offer, Slams Board Over $640M Cash Hoarding - StockTitan
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback - Finansavisen
InMode Enters Oversold Territory (INMD) - Nasdaq
Barclays Has Lowered Expectations for InMode (NASDAQ:INMD) Stock Price - Defense World
InMode: Clearly, I Was Too Optimistic (Rating Downgrade) - Seeking Alpha
JPMorgan Chase & Co. Sells 145,448 Shares of InMode Ltd. (NASDAQ:INMD) - MarketBeat
Needham reiterates Hold on InMode shares amid revenue miss By Investing.com - Investing.com Australia
InMode (NASDAQ:INMD) Price Target Cut to $26.00 by Analysts at Barclays - MarketBeat
Canaccord keeps InMode stock hold rating, $17 price target By Investing.com - Investing.com Nigeria
Canaccord keeps InMode stock hold rating, $17 price target - Investing.com India
Needham reiterates Hold on InMode shares amid revenue miss - Investing.com India
Needham maintains Hold on InMode shares amid revenue miss - Investing.com India
InMode estimates Q4 revenue below consensus - MSN
InMode (NASDAQ:INMD) Shares Gap DownHere's What Happened - MarketBeat
Needham maintains Hold on InMode shares amid revenue miss By Investing.com - Investing.com Canada
InMode to Report Fourth Quarter & Full Year 2024 Financial Resul - GuruFocus.com
Finanzdaten der Inmode Ltd-Aktie (INMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):